We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$150B
AUM Growth
+$12.9B
Cap. Flow
+$4.72B
Cap. Flow %
3.14%
Top 10 Hldgs %
14.8%
Holding
3,187
New
75
Increased
2,456
Reduced
443
Closed
56

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$175M
2
INTC icon
Intel
INTC
+$154M
3
AMZN icon
Amazon
AMZN
+$115M
4
IBM icon
IBM
IBM
+$97.2M
5
PLD icon
Prologis
PLD
+$92.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$156M
2
GGP
GGP Inc.
GGP
+$135M
3
TSM icon
TSMC
TSM
+$111M
4
DCT
DCT Industrial Trust Inc.
DCT
+$81.8M
5
XL
XL Group Ltd.
XL
+$59.6M

Sector Composition

Rank Sector Weight
1 Technology 16.59%
2 Financials 14.04%
3 Healthcare 13.2%
4 Industrials 10.93%
5 Consumer Discretionary 10.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMHI icon
2401
SEACOR Marine Holdings
SMHI
$264M
$2.2M ﹤0.01%
97,210
+12,387
+15% +$272K
GNMK
2402
DELISTED
GenMark Diagnostics, Inc
GNMK
$2.2M ﹤0.01%
299,142
+24,292
+9% +$178K
VYGR icon
2403
Voyager Therapeutics
VYGR
$197M
$2.19M ﹤0.01%
115,987
+14,411
+14% +$277K
LFCR icon
2404
Lifecore Biomedical
LFCR
$183M
$2.17M ﹤0.01%
151,030
+7,305
+5% +$101K
TCRT icon
2405
Alaunos Therapeutics
TCRT
$4.81M
$2.17M ﹤0.01%
4,522
-237
-5% -$102K
KDNY
2406
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.17M ﹤0.01%
59,015
+12,345
+26% +$396K
NNBR icon
2407
NN Inc
NNBR
$301M
$2.15M ﹤0.01%
137,689
-8,188
-6% -$153K
LJPC
2408
DELISTED
La Jolla Pharmaceutical Company
LJPC
$2.15M ﹤0.01%
106,580
-3,000
-3% -$78.4K
ANCX
2409
DELISTED
Access National Corp
ANCX
$2.14M ﹤0.01%
79,083
+3,963
+5% +$111K
MBIN icon
2410
Merchants Bancorp
MBIN
$2.5B
$2.14M ﹤0.01%
126,015
+50,335
+67% +$902K
SGYP
2411
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2.13M ﹤0.01%
1,249,747
-62,283
-5% -$111K
OPCH icon
2412
Option Care Health
OPCH
$3.61B
$2.12M ﹤0.01%
170,999
+8,877
+5% +$104K
ONDK
2413
DELISTED
On Deck Capital, Inc.
ONDK
$2.12M ﹤0.01%
279,893
+31,182
+13% +$243K
CAI
2414
DELISTED
CAI International, Inc.
CAI
$2.09M ﹤0.01%
91,252
+5,741
+7% +$140K
LMNR icon
2415
Limoneira
LMNR
$254M
$2.08M ﹤0.01%
79,676
+17,293
+28% +$481K
PLUG icon
2416
Plug Power
PLUG
$3.1B
$2.07M ﹤0.01%
1,079,716
-61,733
-5% -$120K
CURO
2417
DELISTED
CURO Group Holdings Corp.
CURO
$2.07M ﹤0.01%
68,544
+36,276
+112% +$1.04M
DERM
2418
DELISTED
Dermira, Inc.
DERM
$2.06M ﹤0.01%
189,025
+17,023
+10% +$172K
GLDD
2419
DELISTED
Great Lakes Dredge & Dock
GLDD
$2.06M ﹤0.01%
332,009
+19,119
+6% +$107K
NDLS icon
2420
Noodles & Co
NDLS
$93M
$2.06M ﹤0.01%
21,261
+10,560
+99% +$978K
TTEC icon
2421
TTEC Holdings
TTEC
$85.3M
$2.06M ﹤0.01%
79,413
+4,497
+6% +$131K
PKE icon
2422
Park Aerospace
PKE
$815M
$2.05M ﹤0.01%
105,308
+8,951
+9% +$195K
MG icon
2423
Mistras Group
MG
$592M
$2.02M ﹤0.01%
93,098
+9,091
+11% +$197K
LIND icon
2424
Lindblad Expeditions
LIND
$2.15B
$2.01M ﹤0.01%
135,286
+90,086
+199% +$1.28M
CALX icon
2425
Calix
CALX
$2.49B
$1.99M ﹤0.01%
246,072
+41,205
+20% +$315K

Similar funds

Charles Schwab's Q3 2018 Portfolio in Review

As of Q3 2018, Charles Schwab held 3,187 positions worth $150B, up 9.4% from $137B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Charles Schwab deployed $4.72B of net new capital in Q3 2018, opening 75 new positions and adding to 2,456 existing holdings. Its largest new stake was KKR & Co: 895,988 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $156M trimmed.

  • Charles Schwab's largest Q3 2018 buy was KKR & Co: 895,988 shares worth $24.4M.
  • Charles Schwab added most to Microsoft in Q3 2018, an estimated $175M increase.
  • Charles Schwab's biggest Q3 2018 reduction was Apple, cutting an estimated $156M.
  • Charles Schwab fully exited GGP Inc. in Q3 2018, selling an estimated $135M.
  • Charles Schwab's ten largest holdings make up 15% of its $150B portfolio in Q3 2018.
  • Charles Schwab opened 75 new positions and closed 56 in Q3 2018.
  • Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $150B.

Based on Charles Schwab's 13F filing for Q3 2018, filed 13 Nov 2018.